Bayer AG annual dividends paid
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Bayer AG Dividends Paid Growth & History (BAYN)
Bayer AG paid €127.0M in dividends during fiscal 2025.
View full Bayer AG company overviewBayer AG annual dividends paid history
| Fiscal year | Period ended | Dividends paid | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €127.0M | −€4.0M | −3.05% |
| 2024 | 2024-12-31 | €131.0M | −€2.25B | −94.49% |
| 2023 | 2023-12-31 | €2.38B | €394.0M | +19.85% |
| 2022 | 2022-12-31 | €1.99B | −€8.0M | −0.40% |
| 2021 | 2021-12-31 | €1.99B | €28.1M | +1.43% |
| 2020 | 2020-12-31 | €1.96B | −€786.1M | −28.58% |
| 2019 | 2019-12-31 | €2.75B | €139.8M | +5.36% |
| 2018 | 2018-12-31 | €2.61B | €296.1M | +12.79% |
| 2017 | 2017-12-31 | €2.31B | €82.2M | +3.68% |
| 2016 | 2016-12-31 | €2.23B | €165.8M | +8.02% |
| 2015 | 2015-12-31 | €2.07B | €206.0M | +11.07% |
| 2014 | 2014-12-31 | €1.86B | €124.0M | +7.14% |
| 2013 | 2013-12-31 | €1.74B | €166.0M | +10.57% |
| 2012 | 2012-12-31 | €1.57B | €207.0M | +15.18% |
| 2011 | 2011-12-31 | €1.36B | €124.0M | +10.00% |
| 2010 | 2010-12-31 | €1.24B | — | — |
Bayer AG dividends paid trends
Over the last five fiscal years, Bayer AG's dividends paid decreased from €1.96B to €127.0M, a change of −€1.84B.
About the metric
What dividends paid mean
Dividends paid are cash distributions made to shareholders. The history shows the company’s aggregate cash outflow for dividends, not the dividend per share, dividend yield, or the date an investor receives a payment.
Calculation and source
Reported cash dividends paid
TickerStat standardizes cash dividends paid to common or ordinary shareholders from official cash-flow filings. Reported zero-dividend periods remain zero and are not treated as missing data. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bayer AG source filings ↗Community posts
Bayer wins the first Roundup trial following the Supreme Court ruling
A Missouri jury unanimously ruled for Bayer ($BAYN)’s Monsanto unit in a three-plaintiff Roundup case, rejecting design-defect, fraud and negligence claims. It was the first such trial following the US Supreme Court decision that blocked th ...
Bayer’s Nubeqa cuts risk of metastasis or death in prostate trial
Bayer ($BAYN) disclosed interim Phase 3 results showing that adding Nubeqa to hormone therapy and radiation reduced the risk of metastasis or death by 58% in prostate-cancer patients at high risk of recurrence. Four-year metastasis-free sur ...
